Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In an article, author is Yang, Lily P. H., once mentioned the application of 90-27-7, Name is 2-Phenylbutanoic acid, molecular formula is C10H12O2, molecular weight is 164.2011, MDL number is MFCD00002667, category is benzisoxazole. Now introduce a scientific discovery about this category, SDS of cas: 90-27-7.
Zonisamide, a widely available antiepileptic drug, has been approved in Japan as adjunctive therapy with levodopa for the treatment of previously treated patients with Parkinson’s disease. It is an oral 1,2-benzisoxazole-3-methanesulfonamide and is associated with increased striatal dopamine levels in animal models. In two 12-week, randomized, double-blind, multi-centre trials in adult patients with inadequately controlled Parkinson’s disease and receiving levodopa, zonisamide 25 mg once daily (the recommended dosage) significantly improved motor function from baseline at final assessment, as assessed by the Unified Parkinson’s Disease Rating Scale (UPDRS) Part III total score (primary endpoint), compared with placebo. Zonisamide 25 mg once daily as adjunctive therapy with levodopa was generally well tolerated by patients with Parkinson’s disease. The overall incidence of adverse events was not significantly different between zonisamide 25mg once daily and placebo groups in the phase IIb/III trial.
Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 90-27-7, SDS of cas: 90-27-7.
Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics